Gastroenterology· Topic 5.4 Small intestinal disease· 5.4.1

Celiac disease

Celiac disease is an immune-mediated small-intestinal enteropathy triggered by dietary gluten in genetically predisposed individuals, presenting with malabsorptive diarrhea, iron-deficiency anemia, or dermatitis herpetiformis. Diagnosis requires IgA tissue transglutaminase serology with a total IgA level while the patient still eats gluten, confirmed by duodenal biopsy showing villous atrophy, and the only treatment is a strict lifelong gluten-free diet.

6 min read5 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: celiac disease is an immune-mediated enteropathy of the small intestine triggered by dietary gluten (the storage protein in wheat, rye, and barley) in genetically predisposed individuals.

  • Epidemiology

    Genetically restricted: essentially confined to HLA-DQ2/DQ8 carriers, with northern European descent an associated demographic.

  • Risk factors

    First-degree relative with celiac disease: the strongest identifiable risk factor given the HLA-linked genetic predisposition.

  • Pathophysiology

    Gluten exposure: ingested gliadin (the alcohol-soluble fraction of gluten in wheat, rye, and barley) resists complete digestion and reaches the small intestinal mucosa.

  • Clinical features

    Chronic diarrhea with malabsorptive features: the classic presentation, with bloating, weight loss, and steatorrhea from fat malabsorption; some patients present with constipation or dyspepsia instead.

  • Differential diagnosis

    Tropical sprue: presents identically with diarrhea and malabsorption but follows travel to or residence in the tropics; serology (tissue transglutaminase) is negative and small-bowel biopsy may show…

  • Diagnosis

    Confirm with serology plus duodenal biopsy while the patient is still eating gluten: the best initial test is IgA tissue transglutaminase (tTG-IgA) antibody with a total IgA level, because selective…

  • Management

    Refer to a knowledgeable registered dietitian and start a strict, lifelong gluten-free diet: the only effective treatment, requiring complete avoidance of wheat, rye, and barley, including in…

  • Complications

    Enteropathy-associated T-cell lymphoma: a moderately increased risk of small-bowel T-cell lymphoma is the most serious long-term complication, excluded by duodenal biopsy at diagnosis and considered in refractory or relapsing disease.

  • Prognosis

    Excellent with strict adherence: most patients have complete symptomatic and serologic resolution and normalization of villous architecture on a strict lifelong gluten-free diet.

  • Prevention

    Targeted serologic screening in high-risk groups: check IgA tissue transglutaminase antibody with total IgA in patients with type 1 diabetes mellitus, autoimmune thyroid disease, or a first-degree…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.